{"date":"2025-02-18","count":3,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4192-2025-02-18-1658-rvvpfn","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-02-18","time":"16:58:00","subject":"公告本公司113年第4季財務報告預計提報董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-02-18 16:58，「公告本公司113年第4季財務報告預計提報董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-02-18-1430-1ri5un1","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-02-18","time":"14:30:58","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議解除經理人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-02-18 14:30，「代重要子公司鼎晉生技股份有限公司公告董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-02-18-1430-8nywgm","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-02-18","time":"14:30:24","subject":"代重要子公司鼎晉生技股份有限公司公告新任執行長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-02-18 14:30，「代重要子公司鼎晉生技股份有限公司公告新任執行長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}